PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 87 filers reported holding PAIN THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $380,000 | +56.4% | 425,353 | 0.0% | 0.01% | +66.7% |
Q4 2016 | $243,000 | -44.3% | 425,353 | -2.4% | 0.00% | -50.0% |
Q3 2016 | $436,000 | -54.3% | 435,853 | 0.0% | 0.01% | -60.0% |
Q2 2016 | $955,000 | +27.5% | 435,853 | +29.8% | 0.02% | +15.4% |
Q1 2016 | $749,000 | +27.4% | 335,853 | 0.0% | 0.01% | +18.2% |
Q4 2015 | $588,000 | -3.0% | 335,853 | +1.5% | 0.01% | -15.4% |
Q3 2015 | $606,000 | +35.0% | 330,953 | +27.5% | 0.01% | +44.4% |
Q2 2015 | $449,000 | -1.1% | 259,553 | +8.0% | 0.01% | 0.0% |
Q1 2015 | $454,000 | -38.3% | 240,353 | -33.7% | 0.01% | -47.1% |
Q4 2014 | $736,000 | -28.3% | 362,453 | +38.1% | 0.02% | -34.6% |
Q3 2014 | $1,026,000 | -32.2% | 262,453 | -0.3% | 0.03% | -35.0% |
Q2 2014 | $1,513,000 | +4.9% | 263,153 | +0.3% | 0.04% | -2.4% |
Q1 2014 | $1,443,000 | +13.1% | 262,453 | 0.0% | 0.04% | +5.1% |
Q4 2013 | $1,276,000 | +80.5% | 262,453 | +1.0% | 0.04% | +62.5% |
Q3 2013 | $707,000 | +73.3% | 259,953 | +40.9% | 0.02% | +50.0% |
Q2 2013 | $408,000 | – | 184,553 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,797,689 | $13,597,000 | 9.60% |
SOPHROSYNE CAPITAL LLC | 1,265,020 | $6,147,000 | 5.38% |
Madison Street Partners, LLC | 976,653 | $4,747,000 | 4.46% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 460,000 | $2,236,000 | 2.28% |
Broadfin Capital, LLC | 1,230,000 | $5,978,000 | 0.79% |
683 Capital Management, LLC | 427,071 | $2,076,000 | 0.59% |
AVALON CAPITAL MANAGEMENT | 138,520 | $673,000 | 0.57% |
Cheyne Capital Management (UK) LLP | 92,700 | $451,000 | 0.49% |
Visium Asset Management, LP | 4,350,000 | $21,141,000 | 0.42% |
Gruss Capital Management LP | 789,811 | $3,838,000 | 0.29% |